LungenClinic Großhansdorf GmbH

Großhansdorf, Schleswig-Holstein 22927

0 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer

Studies at this site

• Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer — Stopped early
• TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy — Stopped early